BIZILY SCOTT (Chief Legal Officer) sold 27.5% of their position (3.27K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $39.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.64K
Price / share
$4.14
Trade value
$6.77K
% of position
Common Stock
Shares
−1.64K
Price / share
$12.00
Trade value
$19.62K
% of position
Common Stock
Shares
+1.64K
Price / share
$4.14
Trade value
$6.77K
% of position
Common Stock
Shares
−1.64K
Price / share
$12.20
Trade value
$19.95K
% of position
Net shares
+0.00
Net value
-$26.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2026 | M · Option Exercise | +1.64K | $4.14 | $6.77K | 19.0% | 8.62K | 10.25K |
| Common Stock Direct | 8/13/2026 | S · Sale | −1.64K | $12.00 | $19.62K | 15.9% | 10.25K | 8.62K |
| Common Stock Direct | 8/17/2026 | M · Option Exercise | +1.64K | $4.14 | $6.77K | 19.0% | 8.62K | 10.25K |
| Common Stock Direct | 8/17/2026 | S · Sale | −1.64K | $12.20 | $19.95K | 15.9% | 10.25K | 8.62K |
| Total | +0.00 | -$26.03K | ||||||
Stock Option (Right to Buy)
Common Stock
1.64K shares
Shares
−1.64K
Strike price
4.14
Held after
61.34K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
1.64K shares
Shares
−1.64K
Strike price
4.14
Held after
59.70K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.64K shares | 8/13/2026 | M · Option Exercise | −1.64K | 4.14 | — | 61.34K |
| Stock Option (Right to Buy) Direct | Common Stock1.64K shares | 8/17/2026 | M · Option Exercise | −1.64K | 4.14 | — | 59.70K |